Earnings Summary

Conmed Corp’s revenue jumped 30.37% since last year same period to $327.05Mn in the Q4 2023. On a quarterly growth basis, Conmed Corp has generated 7.38% jump in its revenue since last 3-months.

Conmed Corp’s net profit jumped 24.4% since last year same period to $33.07Mn in the Q4 2023. On a quarterly growth basis, Conmed Corp has generated 108.82% jump in its net profits since last 3-months.

Conmed Corp’s net profit margin fell -4.57% since last year same period to 10.11% in the Q4 2023. On a quarterly growth basis, Conmed Corp has generated 94.48% jump in its net profit margins since last 3-months.

Conmed Corp’s price-to-earnings ratio after this Q4 2023 earnings stands at 35.61.

Conmed Corp’s earning per share (EPS) estimates for the current quarter stand at 0.74 - a -33.33% fall from last quarter’s estimates.

Conmed Corp’s earning per share (EPS) estimates for the current year stand at 0.74.

Conmed Corp’s earning per share (EPS) jumped 152.38% since last year same period to 1.06 in the Q4 2023. This indicates that the Conmed Corp has generated 152.38% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Conmed Corp’s return on assets (ROA) stands at 0.03.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Conmed Corp’s return on equity (ROE) stands at 0.08.

Conmed Corp declared 0.2 dividend per share during the earnings announcement for Q4 2023.